[go: up one dir, main page]

FI940889A7 - Nya isazinoximderivat, deras preparation och användning - Google Patents

Nya isazinoximderivat, deras preparation och användning

Info

Publication number
FI940889A7
FI940889A7 FI940889A FI940889A FI940889A7 FI 940889 A7 FI940889 A7 FI 940889A7 FI 940889 A FI940889 A FI 940889A FI 940889 A FI940889 A FI 940889A FI 940889 A7 FI940889 A7 FI 940889A7
Authority
FI
Finland
Prior art keywords
isazine
preparation
new
oxime derivatives
oxime
Prior art date
Application number
FI940889A
Other languages
English (en)
Finnish (fi)
Other versions
FI107156B (sv
FI940889A0 (sv
Inventor
Frank Watjen
Bjarne Hugo Dahl
Jorgen Drejer
Leif Helth Jensen
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Publication of FI940889A7 publication Critical patent/FI940889A7/sv
Publication of FI940889A0 publication Critical patent/FI940889A0/sv
Application granted granted Critical
Publication of FI107156B publication Critical patent/FI107156B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI940889A 1991-08-28 1994-02-25 Förfarande för framställning av farmakologiskt aktiva indol-2,3-dion-3-oximderivat FI107156B (sv)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US75116591A 1991-08-28 1991-08-28
US75116591 1991-08-28
US83185192A 1992-02-05 1992-02-05
US83185192 1992-02-05
EP9201999 1992-08-27
PCT/EP1992/001999 WO1993005043A1 (en) 1991-08-28 1992-08-27 Novel isatinoxime derivatives, their preparation and use

Publications (3)

Publication Number Publication Date
FI940889A7 true FI940889A7 (sv) 1994-02-25
FI940889A0 FI940889A0 (sv) 1994-02-25
FI107156B FI107156B (sv) 2001-06-15

Family

ID=27115380

Family Applications (1)

Application Number Title Priority Date Filing Date
FI940889A FI107156B (sv) 1991-08-28 1994-02-25 Förfarande för framställning av farmakologiskt aktiva indol-2,3-dion-3-oximderivat

Country Status (18)

Country Link
EP (1) EP0529636B1 (sv)
JP (1) JP3170584B2 (sv)
KR (1) KR100277481B1 (sv)
AT (1) ATE181552T1 (sv)
AU (1) AU655672B2 (sv)
CA (1) CA2076948C (sv)
CZ (1) CZ282759B6 (sv)
DE (1) DE69229461T2 (sv)
DK (1) DK0529636T3 (sv)
FI (1) FI107156B (sv)
GE (1) GEP20002329B (sv)
HU (2) HUT70753A (sv)
MX (1) MX9204914A (sv)
NO (1) NO301117B1 (sv)
PL (1) PL170920B1 (sv)
RU (1) RU2114827C1 (sv)
SK (1) SK280578B6 (sv)
WO (1) WO1993005043A1 (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08502483A (ja) 1992-10-13 1996-03-19 ワーナー−ランバート・コンパニー 新規なキノキサリンジオン誘導体、それらの製造および使用
US5843945A (en) * 1993-05-13 1998-12-01 Neurosearch A/S AMPA antagonists and a method of treatment
FI954965L (sv) * 1993-05-13 1995-11-10 Neurosearch As AMPA-antagonister och behandlingsmetod där dessa används
DK81593D0 (da) * 1993-07-07 1993-07-07 Neurosearch As Nye isatinoximderivater, deres fremstilling og anvendelse
DE69514533T2 (de) * 1994-09-14 2000-07-06 Neurosearch A/S, Ballerup Kondensierte indole und chinoxalinderivate, ihre herstellung und verwendung als glutamatantagonisten
WO1996008494A1 (en) * 1994-09-14 1996-03-21 Neurosearch A/S Indole-2,3-dione-3-oxime derivatives, their preparation and use
UA54403C2 (uk) * 1996-10-01 2003-03-17 Н'Юросерч А/С Похідні індол-2,3-діон-3-оксиму, фармацевтична композиція, спосіб лікування розладу чи захворювання ссавців, у тому числі людини та спосіб одержання похідних індол-2,3-діон-3-оксиму
FR2768624B1 (fr) * 1997-09-25 1999-11-12 Oreal Utilisation d'un inhibiteur d'acides amines excitateurs dans une composition cosmetique ou dermatologique pour peaux sensibles et composition obtenue
DK1183025T3 (da) 1999-05-19 2009-05-04 Painceptor Pharma Corp Hæmmere af proton-styrede kationskanaler og deres anvendelse til behandling af iskæmiske lidelser
AU781067B2 (en) 2000-01-24 2005-05-05 Neurosearch A/S Isatine derivatives with neurotrophic activity
AU2003273114A1 (en) 2002-10-29 2004-05-25 Sungkyunkwan University Medicament component of berberine for the use of prevention and treatment of psycological dependence on and analgesic tolerance to morphine
BRPI0618863A2 (pt) 2005-11-23 2016-09-13 Painceptor Pharma Corp métodos de modular a atividade de um canal iônico dependente e de tratar dor, uma transtorno associado aos sistemas genitourinário ou gastrointestinal em um indivíduo e, composto
EA027009B1 (ru) * 2012-12-19 2017-06-30 Байер Кропсайенс Акциенгезельшафт Дифторметилникотиновые инданилкарбоксамиды
US9815768B2 (en) * 2014-02-28 2017-11-14 Sumitomo Chemical Company, Limited Method for producing 2-(halogenomethyl)-3-methylnitrobenzene
CA3017751A1 (en) * 2016-03-17 2017-09-21 Fmc Corporation Process for converting s-enantiomer to its racemic form
CN112266368B (zh) * 2017-11-15 2024-03-19 中山光禾医疗科技有限公司 光交联水凝胶材料的制备、原料、产品及应用
CN108912127B (zh) * 2018-08-27 2019-12-10 青岛农业大学 一种基于靛红骨架的苯并[b,e]氮杂卓化合物及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE69677B1 (en) * 1989-12-11 1996-10-02 Neurosearch As Isatine derivatives their preparation and use

Also Published As

Publication number Publication date
CZ282759B6 (cs) 1997-09-17
HUT70753A (en) 1995-10-30
NO301117B1 (no) 1997-09-15
KR100277481B1 (ko) 2001-02-01
CA2076948A1 (en) 1993-03-01
DE69229461T2 (de) 1999-10-21
ATE181552T1 (de) 1999-07-15
FI107156B (sv) 2001-06-15
GEP20002329B (en) 2000-12-25
HU211632A9 (en) 1995-12-28
NO940676D0 (no) 1994-02-25
RU2114827C1 (ru) 1998-07-10
SK280578B6 (sk) 2000-04-10
WO1993005043A1 (en) 1993-03-18
CZ39594A3 (en) 1994-11-16
CA2076948C (en) 2002-04-16
AU2482092A (en) 1993-04-05
JP3170584B2 (ja) 2001-05-28
HU9400595D0 (en) 1994-05-30
DK0529636T3 (da) 1999-12-13
PL170920B1 (pl) 1997-02-28
AU655672B2 (en) 1995-01-05
MX9204914A (es) 1993-07-01
DE69229461D1 (de) 1999-07-29
EP0529636A1 (en) 1993-03-03
SK23894A3 (en) 1994-12-07
JPH06510056A (ja) 1994-11-10
NO940676L (sv) 1994-04-27
FI940889A0 (sv) 1994-02-25
EP0529636B1 (en) 1999-06-23

Similar Documents

Publication Publication Date Title
FI955248A7 (sv) 1-Bifenylmetylimidazolderivat, framställning och terapeutisk användning av dessa
FI934426A7 (sv) Tiazolidindionderivat, framställning och användning därav
FI935074A7 (sv) Nya tiopyranopyrrolderivat och framställning av dem
FI952179A7 (sv) Nya 3,3-difenylpropylaminer, användning och framställning därav
FI955235L (sv) Oxazolidindionderivat, deras framställning och användning
FI935072A7 (sv) Nya perhydroisoindoler och deras framställning
FI935897L (sv) Pyridopyrimidinderivat deras framstaellning och anvaendning
FI935887L (sv) Tiazolidindionderivat, deras framstaellning och anvaendning
FI921459A7 (sv) Piperidinderivat, framställning av dessa samt terapeutisk användning av dessa
FI940696A7 (sv) Nya pyrazinderivat, deras framställning och användning
FI915099A7 (sv) Tienoimidazolderivat, deras framställning och användning
FI940889A7 (sv) Nya isazinoximderivat, deras preparation och användning
FI914611A7 (sv) 2-aminopyrimidin-4-karboxamidderivat, framställning och terapeutisk användning av dem
FI931011A7 (sv) Kondenserade heterocykliska ketonderivat, deras framställning och användning
FI941287L (sv) Triazolokinoxalin-1,4-dioner och framställning och användning av dem
FI922982A7 (sv) 2-aminopyrimidin-4-karboxamidderivat, framställning av dessa och terapeutisk användning av dessa
FI934680A7 (sv) Arylmorfolin, framställning och använding
FI930716A7 (sv) Nya arylkarbonylaminoalkyldihydrooxopyridiner, framställning och användning av dessa
FI955679A0 (sv) Piperidinderivater, framställning och användning därav
FI944040A7 (sv) Laktolderivat, deras framställning och användning
FI923458A7 (sv) 4,5-cykloalkano-3-benzazepin-7-olderivat och deras användning
FI921814A7 (sv) 2-aminopyrimidin-4-karboxiamidderivat, deras framställning och terapeutisk användning av dem
FI920663A7 (sv) Polyhydroxicyklopentanderivat, deras framställning och terapeutiska användning
FI941963L (sv) Pyridinderivat, deras framställning och användning
FI924053A7 (sv) Substituerade aminopropaner, förfarande för deras framställning och deras användning